drugset / Trial / NCT03536598
Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the safety and efficacy of CJ-30060 compared with amlodipine/valsartan combination therapy and valsartan/rosuvastatin combination therapy in hypertensive patients with hyperlipidemia
Timeline
- Start
- 2016-10-14
- Primary completion
- 2017-09-04
- Completion
- 2017-09-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amlodipine | Other / unclassified | 10 mg | — |
| Comparator | Rosuvastatin | Small molecule | 20 mg | — |
| Comparator | Valsartan | Small molecule | 160 mg | — |